SG11201608031PA - 4'-substituted nucleoside-derivatives as hiv reverse transcriptase inhibitors - Google Patents

4'-substituted nucleoside-derivatives as hiv reverse transcriptase inhibitors

Info

Publication number
SG11201608031PA
SG11201608031PA SG11201608031PA SG11201608031PA SG11201608031PA SG 11201608031P A SG11201608031P A SG 11201608031PA SG 11201608031P A SG11201608031P A SG 11201608031PA SG 11201608031P A SG11201608031P A SG 11201608031PA SG 11201608031P A SG11201608031P A SG 11201608031PA
Authority
SG
Singapore
Prior art keywords
derivatives
reverse transcriptase
transcriptase inhibitors
hiv reverse
substituted nucleoside
Prior art date
Application number
SG11201608031PA
Inventor
Vinay M Girijavallabhan
David B Olsen
Zhibo Zhang
Jianmin Fu
Bing-Yu Tang
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52824598&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201608031P(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of SG11201608031PA publication Critical patent/SG11201608031PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201608031PA 2014-03-28 2015-03-26 4'-substituted nucleoside-derivatives as hiv reverse transcriptase inhibitors SG11201608031PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2014/074294 WO2015143712A1 (en) 2014-03-28 2014-03-28 4'-substituted nucleoside reverse transcriptase inhibitors
PCT/US2015/022621 WO2015148746A1 (en) 2014-03-28 2015-03-26 4'-substituted nucleoside-derivatives as hiv reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
SG11201608031PA true SG11201608031PA (en) 2016-10-28

Family

ID=52824598

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201608031PA SG11201608031PA (en) 2014-03-28 2015-03-26 4'-substituted nucleoside-derivatives as hiv reverse transcriptase inhibitors

Country Status (41)

Country Link
US (2) US9777035B2 (en)
EP (1) EP3122752B1 (en)
JP (1) JP6182680B2 (en)
KR (1) KR101961009B1 (en)
CN (1) CN106795199B (en)
AP (1) AP2016009482A0 (en)
AR (1) AR099788A1 (en)
AU (2) AU2015236018B2 (en)
CA (1) CA2943792C (en)
CL (1) CL2016002414A1 (en)
CR (1) CR20160451A (en)
CY (1) CY1124829T1 (en)
DK (1) DK3122752T3 (en)
DO (1) DOP2016000265A (en)
EA (1) EA031476B1 (en)
EC (1) ECSP16085206A (en)
ES (1) ES2894228T3 (en)
GE (1) GEP20197009B (en)
GT (1) GT201600201A (en)
HR (1) HRP20211622T1 (en)
HU (1) HUE056913T2 (en)
IL (1) IL247923B (en)
JO (1) JO3636B1 (en)
LT (1) LT3122752T (en)
MA (1) MA39809B1 (en)
MD (1) MD4812C1 (en)
MX (1) MX367058B (en)
MY (1) MY194635A (en)
NI (1) NI201600145A (en)
NZ (1) NZ724343A (en)
PE (1) PE20170197A1 (en)
PH (1) PH12016501897A1 (en)
PL (1) PL3122752T3 (en)
PT (1) PT3122752T (en)
RS (1) RS62418B1 (en)
SG (1) SG11201608031PA (en)
SI (1) SI3122752T1 (en)
SV (1) SV2016005290A (en)
TW (1) TWI660967B (en)
UA (1) UA120758C2 (en)
WO (2) WO2015143712A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41213A (en) * 2014-12-19 2017-10-24 Alios Biopharma Inc SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGUES OF THEM
EP3334745B1 (en) 2015-08-13 2024-05-15 Merck Sharp & Dohme LLC Cyclic di-nucleotide compounds as sting agonists
US11453697B1 (en) 2015-08-13 2022-09-27 Merck Sharp & Dohme Llc Cyclic di-nucleotide compounds as sting agonists
CA2998646C (en) * 2015-09-23 2021-05-18 Merck Sharp & Dohme Corp. 4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof
JOP20170038B1 (en) * 2016-02-12 2021-08-17 Merck Sharp & Dohme Compounds for use for treatment and prophylaxis of HIV infection
WO2017223414A1 (en) 2016-06-24 2017-12-28 Incyte Corporation HETEROCYCLIC COMPOUNDS AS PI3K-γ INHIBITORS
CR20190168A (en) 2016-10-04 2019-05-17 Merck Sharp & Dohme BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
JP7125714B2 (en) * 2016-12-13 2022-08-25 ヤマサ醤油株式会社 2'-Deoxy-7-deazapurine nucleoside derivatives with antiviral activity
EP3621624B1 (en) 2017-05-12 2023-08-30 Merck Sharp & Dohme LLC Cyclic di-nucleotide compounds as sting agonists
AU2018311965A1 (en) 2017-08-04 2020-02-13 Merck Sharp & Dohme Llc Combinations of PD-1 antagonists and benzo[b]thiophene sting antagonists for cancer treatment
US11285131B2 (en) 2017-08-04 2022-03-29 Merck Sharp & Dohme Corp. Benzo[b]thiophene STING agonists for cancer treatment
EP3684782A1 (en) * 2017-09-18 2020-07-29 Janssen BioPharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2019125974A1 (en) 2017-12-20 2019-06-27 Merck Sharp & Dohme Corp. Cyclic di-nucleotide compounds as sting agonists
MX2020006864A (en) * 2017-12-27 2020-11-11 Univ Emory Combined modalities for nucleosides and/or nadph oxidase (nox) inhibitors as myeloid-specific antiviral agents.
EP3762396A1 (en) * 2018-03-07 2021-01-13 GlaxoSmithKline Intellectual Property (No.2) Limited Compounds useful in hiv therapy
BR112020020085A8 (en) 2018-04-03 2023-04-11 Merck Sharp & Dohme COMPOUND, PHARMACEUTICAL COMPOSITION, AND METHODS FOR INDUCING AN IMMUNE RESPONSE, FOR INDUCING STING-DEPENDENT TYPE I INTERFERON PRODUCTION, AND FOR TREAT A CELL PROLIFERATION DISORDER
US11702430B2 (en) 2018-04-03 2023-07-18 Merck Sharp & Dohme Llc Aza-benzothiophene compounds as STING agonists
WO2020014041A1 (en) * 2018-07-09 2020-01-16 Merck Sharp & Dohme Corp. Enzymatic synthesis of 4'-ethynyl nucleoside analogs
CA3108635A1 (en) * 2018-08-09 2020-02-13 Glaxosmithkline Intellectual Property (No.2) Limited Compounds useful in hiv therapy
UA128041C2 (en) 2019-01-25 2024-03-20 Браун Юніверсіті Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders
CN113811360A (en) * 2019-03-06 2021-12-17 葛兰素史密斯克莱知识产权（第2 号）有限公司 Compounds for HIV treatment
CN110054654B (en) * 2019-05-27 2022-12-27 武汉百科药物开发有限公司 Synthetic method of decitabine intermediate alpha-substituted deoxyribose
US20220332751A1 (en) * 2019-09-11 2022-10-20 The Scripps Research Institute Antiviral prodrugs and pharmaceutical compositions thereof
CA3164528A1 (en) * 2019-12-09 2021-06-17 Viiv Healthcare Company Pharmaceutical compositions comprising cabotegravir
TWI794742B (en) 2020-02-18 2023-03-01 美商基利科學股份有限公司 Antiviral compounds
CN112321589B (en) * 2020-02-18 2022-05-03 山东科巢生物制药有限公司 Synthesis method of antiviral drug Reidesciclovir and intermediate thereof
TW202200161A (en) 2020-03-20 2022-01-01 美商基利科學股份有限公司 Prodrugs of 4’-c-substituted-2-halo-2’-deoxyadenosine nucleosides and methods of making and using the same
CN112778310A (en) * 2020-04-20 2021-05-11 中国科学院上海药物研究所 Application of nucleoside analogue or combination preparation containing nucleoside analogue in resisting virus
CN113527303B (en) * 2020-04-21 2022-06-10 浙江工业大学 Preparation process of Rudexivirin nucleus intermediate
CN113637041B (en) * 2020-05-11 2024-02-27 上海科胜药物研发有限公司 Preparation method of ribonucleoside
CN116194144A (en) 2020-08-07 2023-05-30 吉利德科学公司 Prodrugs of phosphoramide nucleotide analogs and pharmaceutical uses thereof
WO2022074391A1 (en) 2020-10-08 2022-04-14 Storm Therapeutics Limited Compounds inhibitors of mettl3
CN112300236A (en) * 2020-10-21 2021-02-02 佛山科学技术学院 Nucleotide mixed phosphoramidate compounds, pharmaceutical compositions thereof, and uses thereof
KR20230132476A (en) 2021-01-25 2023-09-15 브리 바이오사이언시스, 인크. Adenosine derivatives and pharmaceutical compositions containing them
CA3204255A1 (en) 2021-01-25 2022-07-28 Lianhong Xu Combination therapy for hiv with adenosine derivative and capsid inhibitors
US11697666B2 (en) 2021-04-16 2023-07-11 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
PE20240654A1 (en) 2021-08-20 2024-04-04 Shionogi & Co NUCLEOSIDE DERIVATIVES AND PRODRUGS THEREOF THAT HAVE INHIBITORY ACTION OF VIRAL GROWTH
WO2023046900A1 (en) 2021-09-23 2023-03-30 Katholieke Universiteit Leuven Ribonucleoside analogues against -sars-cov-2

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681941A (en) 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
AU651569B2 (en) 1990-01-11 1994-07-28 Isis Pharmaceuticals, Inc. Compositions and methods for detecting and modulating RNA activity and gene expression
ATE271063T1 (en) 1996-10-16 2004-07-15 Icn Pharmaceuticals PURINE-L-NUCLEOSIDES, THEIR ANALOGUES AND USES
DE60005502T2 (en) 1999-05-12 2004-06-24 Yamasa Corp., Choshi 4'-C-ETHYNYL-PURINE-NUCLEOSIDES
US6831069B2 (en) 1999-08-27 2004-12-14 Ribapharm Inc. Pyrrolo[2,3-d]pyrimidine nucleoside analogs
WO2003062256A1 (en) 2002-01-17 2003-07-31 Ribapharm Inc. 2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
US20040014957A1 (en) 2002-05-24 2004-01-22 Anne Eldrup Oligonucleotides having modified nucleoside units
US20040229839A1 (en) 2003-05-14 2004-11-18 Biocryst Pharmaceuticals, Inc. Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
WO2004106356A1 (en) 2003-05-27 2004-12-09 Syddansk Universitet Functionalized nucleotide derivatives
WO2005003047A1 (en) 2003-07-03 2005-01-13 Philips Intellectual Property & Standards Gmbh Pane which can be heated by means of invisible light
CA2502109C (en) 2004-03-24 2010-02-23 Yamasa Corporation 4'-c-substituted-2-haloadenosine derivative
JP2009526850A (en) 2006-02-14 2009-07-23 メルク エンド カムパニー インコーポレーテッド Nucleoside aryl phosphoramidates for treating RNA-dependent RNA viral infections
US7960569B2 (en) 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US7951789B2 (en) 2006-12-28 2011-05-31 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
CN101003550B (en) * 2006-12-30 2010-05-19 河南省分析测试研究中心 8- halogenated adenine nucleotide compound , synthetic method, medical application
ES2390188T3 (en) 2007-01-12 2012-11-07 Biocryst Pharmaceuticals, Inc. Antiviral Nucleoside Analogs
CN100532388C (en) * 2007-07-16 2009-08-26 郑州大学 2'-fluorine-4'-substituted-nucleosides analog, preparation method and uses thereof
US20090318380A1 (en) 2007-11-20 2009-12-24 Pharmasset, Inc. 2',4'-substituted nucleosides as antiviral agents
PT2268642E (en) 2008-04-23 2015-06-02 Gilead Sciences Inc 1' -substituted carba-nucleoside analogs for antiviral treatment
WO2010036407A2 (en) 2008-05-15 2010-04-01 Biocryst Pharmaceuticals, Inc. Antiviral nucleoside analogs
EP2313102A2 (en) 2008-07-03 2011-04-27 Biota Scientific Management Bycyclic nucleosides and nucleotides as therapeutic agents
GB0815968D0 (en) 2008-09-03 2008-10-08 Angeletti P Ist Richerche Bio Antiviral agents
WO2010027005A1 (en) 2008-09-05 2010-03-11 壽製薬株式会社 Substituted amine derivative and medicinal composition comprising same as the active ingredient
EP2376514A2 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
MX2011006891A (en) 2008-12-23 2011-10-06 Pharmasset Inc Nucleoside phosphoramidates.
DE102009000180A1 (en) 2009-01-13 2010-07-15 Evonik Degussa Gmbh Process for the preparation of multilayer coated rubber particles and multilayer coated rubber particles
GB0900914D0 (en) 2009-01-20 2009-03-04 Angeletti P Ist Richerche Bio Antiviral agents
JP2012521359A (en) 2009-03-20 2012-09-13 アリオス バイオファーマ インク． Substituted nucleoside and nucleotide analogs
US8927513B2 (en) 2009-07-07 2015-01-06 Alnylam Pharmaceuticals, Inc. 5′ phosphate mimics
PE20121480A1 (en) 2009-12-17 2012-11-10 Merck Sharp & Dohme AMINOPYRIMIDINES AS SYK INHIBITORS
AU2011258005A1 (en) 2010-05-28 2013-01-17 Biocryst Pharmaceuticals, Inc. Heterocyclic compounds as Janus kinase inhibitors
AU2011280910B2 (en) 2010-07-22 2015-07-09 Gilead Sciences, Inc. Methods and compounds for treating Paramyxoviridae virus infections
TW201305185A (en) 2010-09-13 2013-02-01 Gilead Sciences Inc 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
EP3932931A1 (en) * 2012-03-13 2022-01-05 Gilead Sciences, Inc. A nebulizer comprising a pharmaceutical composition comprising 2'- substituted carba-nucleoside analogs for antiviral treatment
UA119050C2 (en) * 2013-11-11 2019-04-25 Ґілеад Саєнсиз, Інк. Pyrrolo [1,2,f] [1,2,4] triazines useful for treating respiratory syncitial virus infections

Also Published As

Publication number Publication date
NZ724343A (en) 2020-02-28
TW201619180A (en) 2016-06-01
WO2015143712A1 (en) 2015-10-01
CY1124829T1 (en) 2022-11-25
UA120758C2 (en) 2020-02-10
US20180002366A1 (en) 2018-01-04
PL3122752T3 (en) 2022-01-03
MY194635A (en) 2022-12-08
MX367058B (en) 2019-08-02
MD4812C1 (en) 2023-01-31
IL247923B (en) 2021-01-31
GT201600201A (en) 2018-12-18
CN106795199B (en) 2020-01-10
AU2017225090A1 (en) 2017-09-28
JP6182680B2 (en) 2017-08-16
MD20160117A2 (en) 2017-02-28
MA39809B1 (en) 2021-10-29
RS62418B1 (en) 2021-10-29
US20150274767A1 (en) 2015-10-01
GEP20197009B (en) 2019-08-12
SV2016005290A (en) 2018-05-03
PE20170197A1 (en) 2017-03-22
AU2015236018A1 (en) 2016-10-06
EA201691931A1 (en) 2017-02-28
IL247923A0 (en) 2016-11-30
CL2016002414A1 (en) 2017-05-05
KR20160128437A (en) 2016-11-07
ES2894228T3 (en) 2022-02-14
NI201600145A (en) 2016-10-27
EA031476B1 (en) 2019-01-31
EP3122752A1 (en) 2017-02-01
CR20160451A (en) 2016-12-06
HUE056913T2 (en) 2022-03-28
AU2015236018B2 (en) 2017-09-28
PT3122752T (en) 2021-10-20
US9777035B2 (en) 2017-10-03
MX2016012659A (en) 2016-12-14
AR099788A1 (en) 2016-08-17
DOP2016000265A (en) 2017-04-30
HRP20211622T1 (en) 2022-03-04
DK3122752T3 (en) 2021-10-25
BR112016022438A8 (en) 2021-06-29
KR101961009B1 (en) 2019-03-21
WO2015148746A1 (en) 2015-10-01
CN106795199A (en) 2017-05-31
JO3636B1 (en) 2020-08-27
AP2016009482A0 (en) 2016-10-31
MA39809A (en) 2021-04-07
CA2943792A1 (en) 2015-10-01
MD4812B1 (en) 2022-06-30
BR112016022438A2 (en) 2017-08-15
PH12016501897A1 (en) 2016-12-19
TWI660967B (en) 2019-06-01
LT3122752T (en) 2021-11-10
ECSP16085206A (en) 2017-08-31
CA2943792C (en) 2020-02-25
AU2017225090B2 (en) 2018-08-09
SI3122752T1 (en) 2021-11-30
EP3122752B1 (en) 2021-08-25
JP2017512797A (en) 2017-05-25

Similar Documents

Publication Publication Date Title
SG11201608031PA (en) 4'-substituted nucleoside-derivatives as hiv reverse transcriptase inhibitors
IL269635B (en) Quinazoline derivatives used to treat hiv
IL246785A0 (en) Benzimidazol-2-amines as midh1 inhibitors
HK1226398A1 (en) Benzimidazol-2-amines as midh1 inhibitors
SG10201500647RA (en) Holding table
LT3125894T (en) Prodrugs of hiv reverse transcriptase inhibitors
EP3387002A4 (en) Dimeric reverse transcriptase
LT3227325T (en) Selective il-6-trans-signalling inhibitor compositions
GB201408233D0 (en) Use of polyanionic composition
ES1112830Y (en) TABLE BARBECUE
ZA201606413B (en) 4'-substituted nucleoside-reverse transcriptase inhibitors .
AU364190S (en) Side table
AU364177S (en) Side Table
AU364176S (en) Side table
AU357872S (en) Dining table
GB201406907D0 (en) Table
GB201418645D0 (en) Shelf